Citations (57)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Marie-Élaine Plante, Xue Feng & Jean-Samuel Boudreault. (2023) Single-center retrospective study assessing the efficacy and safety of BeEAM (bendamustine, etoposide, cytarabine, melphalan) as conditioning regimen for autologous hematopoietic stem cell transplantation. Leukemia & Lymphoma 64:7, pages 1234-1242.
Read now
Read now
Meng Lin, Xiaolong Wu, Lei Zhang, Ling Li, Xinhua Wang, Xiaorui Fu, Zhenchang Sun, Xudong Zhang, Linan Zhu, Hui Yu, Yu Chang, Feifei Nan, Jiaqin Yan, Zhiyuan Zhou, Cunzhen Shi, Mingzhi Zhang & Xin Li. (2023) Fotemustine, etoposide, cytarabine, and cyclophosphamide (FEAC) conditioning regimen for autologous stem cell transplantation in lymphoma. Leukemia & Lymphoma 64:3, pages 605-612.
Read now
Read now
Nina D. Wagner-Johnston, Andrè Goy, Maria A. Rodriguez, W. Christopher Ehmann, Paul A. Hamlin, John Radford, Catherine Thieblemont, Cheolwon Suh, John Sweetenham, Yifan Huang, Sharon T. Sullivan, Erik R. Vandendries & Christian Gisselbrecht. (2015) A phase 2 study of inotuzumab ozogamicin and rituximab, followed by autologous stem cell transplant in patients with relapsed/refractory diffuse large B-cell lymphoma. Leukemia & Lymphoma 56:10, pages 2863-2869.
Read now
Read now
Yujin Kobayashi, Yoshihiro Hatta, Masahiko Sugitani, Atsuko Hojo, Masaru Nakagawa, Machiko Kusuda, Yoshihito Uchino, Hiromichi Takahashi, Satomi Kiso, Yukio Hirabayashi, Mai Yagi, Hitomi Kodaira, Daisuke Kurita, Katsuhiro Miura, Noriyoshi Iriyama, Sumiko Kobayashi, Yoshimasa Kura, Akira Horikoshi, Umihiko Sawada, Jin Takeuchi & Masami Takei. (2014) Safety and efficacy of high-dose cyclophosphamide, etoposide and ranimustine regimen followed by autologous peripheral blood stem cell transplant for patients with diffuse large B-cell lymphoma. Leukemia & Lymphoma 55:11, pages 2514-2519.
Read now
Read now
Andrew A. Lane, Philippe Armand, Yang Feng, Donna S. Neuberg, Jeremy S. Abramson, Jennifer R. Brown, David C. Fisher, Ann S. LaCasce, Eric D. Jacobsen, Steven L. McAfee, Thomas R. Spitzer, Arnold S. Freedman & Yi-Bin Chen. (2012) Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU and etoposide followed by autologous stem cell transplant. Leukemia & Lymphoma 53:6, pages 1130-1136.
Read now
Read now
Silke Andresen, Juliane Brandt, Sascha Dietrich, Marie-Luise Memmer, Anthony D. Ho & Mathias Witzens-Harig. (2012) The impact of high-dose chemotherapy, autologous stem cell transplant and conventional chemotherapy on quality of life of long-term survivors with follicular lymphoma. Leukemia & Lymphoma 53:3, pages 386-393.
Read now
Read now
Juliane Brandt, Sascha Dietrich, Julia Meissner, Kai Neben, Anthony D. Ho & Mathias Witzens-Harig. (2010) Quality of life of long-term survivors with Hodgkin lymphoma after high-dose chemotherapy, autologous stem cell transplantation, and conventional chemotherapy. Leukemia & Lymphoma 51:11, pages 2012-2020.
Read now
Read now
Noemí Puig, Javier De La Rubia, Isidro Jarque, Miguel Salavert, Federico Moscardó, Jaime Sanz, Ignacio Lorenzo, Pau Montesinos, Guillermo Martín, Jesús Martínez, Guillermo Sanz, Margarita Blanes & Miguel Sanz. (2007) Characteristics of and risk factors for pneumonia in patients with hematological malignancies developing fever after autologous blood stem cell transplantation. Leukemia & Lymphoma 48:12, pages 2367-2374.
Read now
Read now
Koen Van Besien. (2006) Toxicity of high dose BCNU: How much is too much?. Leukemia & Lymphoma 47:8, pages 1447-1448.
Read now
Read now
Articles from other publishers (48)
Honghao Gao, Ningjing Lin, Zhenyang Gu, Shihua Zhao, Xiaopei Wang, Shunzong Yuan, Yuqin Song, Jun Zhu, Wenrong Huang, Weiping Liu & Chunji Gao. (2023)
Up‐front autologous hematopoietic stem cell transplantation after first complete remission improved prognosis of advanced extra‐nodal
NKT
cell lymphoma: A multicenter real‐world study in China
. European Journal of Haematology 110:6, pages 680-687.
Crossref
Crossref
Ran Wu & Liyuan Ma. (2023) BeEAM (Bendamustine, Etoposide, Cytarabine, Melphalan) Versus BEAM (Carmustine, Etoposide, Cytarabine, Melphalan) as Conditioning Regimen Before Autologous Haematopoietic Cell Transplantation: A Systematic Review and Meta-Analysis. Cell Transplantation 32.
Crossref
Crossref
Sanjeev Kumar SharmaSanjeev Kumar Sharma. 2023. Basics of Hematopoietic Stem Cell Transplant. Basics of Hematopoietic Stem Cell Transplant
335
364
.
Xuan Ni Tan, Chang Yang Yew, Scott J. Ragg, Rosemary A. Harrup & Anna M. Johnston. (2022) Outpatient autologous stem cell transplantation in Royal Hobart Hospital, Tasmania: a single‐centre, retrospective review in the Australian setting. Internal Medicine Journal 52:7, pages 1242-1250.
Crossref
Crossref
Anthony D. Sung, Vinay K. Giri, Helen Tang, Krista Rowe Nichols, Meagan V. Lew, Lauren Bohannon, Yi Ren, Sin-Ho Jung, Tara Dalton, Amy Bush, Jolien Van Opstal, Alexandra Artica, Julia Messina, Rebecca Shelby, Jennifer Frith, Martha Lassiter, Jill Burleson, Kari Leonard, Ashley S. Potter, Taewoong Choi, Cristina J. Gasparetto, Mitchell E. Horwitz, Gwynn D. Long, Richard D. Lopez, Stefanie Sarantopoulos & Nelson J. Chao. (2022) Home-Based Hematopoietic Cell Transplantation in the United States. Transplantation and Cellular Therapy 28:4, pages 207.e1-207.e8.
Crossref
Crossref
Narendran Krishnamoorthi, Bhanu Prakash, Dhanraju KM, Chinmaya Kumar Pani, Malliha Ram, Kalpana Rajesh, Biswajit Dubashi, Prasanth Ganesan & Smita Kayal. (2022) Outcome of CBV (Carmustine, Cyclophosphamide, Etoposide) Conditioning Regimen for Autologous Stem Cell Transplant in Lymphoma: A Retrospective Study from a Tertiary Cancer Center in South India. Indian Journal of Medical and Paediatric Oncology.
Crossref
Crossref
Jaqueline Sapelli, Jayr Schmidt Filho, Garles Miller Matias Vieira, Fernanda Lemos Moura, Janaina Naiara Germano & Vladmir Cláudio Cordeiro de Lima. (2021) BuCyE can safely replace BEAM as a conditioning regimen for autologous stem cell transplantation in the treatment of refractory and relapsed lymphomas. Leukemia Research 110, pages 106689.
Crossref
Crossref
Daria Aleksandrovna Koroleva & E.E. Zvonkov. (2021) Carmustine in the Therapy of B-Cell Lymphomas. Clinical oncohematology 14:4, pages 496-502.
Crossref
Crossref
Ahmet Kursad Gunes, Simten Dagdas, Funda Ceran, Mehmet Ali Ucar, Mesude Falay, Cenk Sunu, Meltem Ayli, Nurullah Zengin & Gulsum Ozet. (2020) Conditioning Regimens for Relapsed/Refractory Lymphoma Patients Undergoing Autologous Stem Cell Transplantation: BEAM Versus High Dose ICE. Indian Journal of Hematology and Blood Transfusion 37:1, pages 82-89.
Crossref
Crossref
Jérôme Cornillon, Elisabeth Daguenet, Jacques-Olivier Bay, Adrien Chauchet, Gilles Salles, Nathalie Contentin, Emmanuelle Nicolas-Virelizier, Mélanie Mercier, Nicolas Vallet, Magda Alexis, Marie-Lorraine Chrétien, Thomas Cluzeau, Anne Huynh, Chantal Himberlin, Véronique Dorvaux, Sandy Amorim, Caroline Lejeune, Régis Peffault de Latour & Emmanuel Gyan. (2019) BAM conditioning before autologous transplantation for lymphoma: a study on behalf of the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC). Annals of Hematology 98:8, pages 1973-1980.
Crossref
Crossref
Christopher Lemieux, Imran Ahmad, Nadia M. Bambace, Léa Bernard, Sandra Cohen, Jean-Sébastien Delisle, Isabelle Fleury, Thomas Kiss, Luigina Mollica, Denis-Claude Roy, Guy Sauvageau, Jean Roy & Silvy Lachance. (2019) Outcome of autologous hematopoietic stem cell transplant in older patients with B cell lymphoma when selected for fitness and chemosensitive disease. Leukemia Research 79, pages 75-80.
Crossref
Crossref
Daria Gaut & Gary J. Schiller. (2019) Hematopoietic stem cell transplantation in primary central nervous system lymphoma: a review of the literature. International Journal of Hematology 109:3, pages 260-277.
Crossref
Crossref
Munira Shabbir-MoosajeeSamad JehangirSobiya SawaniTariq MuhammedNatasha AliUsman SheikhSalman Adil. (2019) Safety and efficacy of bendamustine in the conditioning regimen for autologous stem cell transplantation in patients with relapsed/refractory lymphoma. Blood Research 54:2, pages 108.
Crossref
Crossref
Simon C. Ling & Ines Loverdos. 2019. Pediatric Hepatology and Liver Transplantation. Pediatric Hepatology and Liver Transplantation
329
344
.
M. A. Bekadja, S. Talhi, K. Amani, S. Osmani, M. Brahimi, M. A. Mazari, A. Krim, N. Yafour, B. Entasoltan, S. Bouchama, L. Charef, F. Serradj, R. Bouhass & A. Arabi. (2018) Outcomes of modified-eam conditioned autologous non-cryopreserved hematopoietic sct for lymphoma. A retrospective single-centre study. Bone Marrow Transplantation 53:12, pages 1596-1598.
Crossref
Crossref
Takanobu Morishita, Motohito Okabe, Yuuka Kawaguchi, Yoonha Lee, Marie Ohbiki, Masahide Osaki, Miyo Goto, Hiroaki Araie, Takahiko Sato, Tatsunori Goto, Yukiyasu Ozawa & Koichi Miyamura. (2018) Higher Peak Tacrolimus Concentrations after Allogeneic Hematopoietic Stem Cell Transplantation Increase the Risk of Endothelial Cell Damage Complications. Biology of Blood and Marrow Transplantation 24:12, pages 2509-2516.
Crossref
Crossref
Sylvain P. Chantepie, Sylvain Garciaz, Emmanuelle Tchernonog, Frederic Peyrade, Marie‐Virginie Larcher, Momar Diouf, Luc‐Mathieu Fornecker, Roch Houot, Thomas Gastinne, Carole Soussain, Sandra Malak, Richard Lemal, Caroline Delette, Ahmad Ibrahim, Anne‐Claire Gac, Emilie Reboursière, Jean‐Pierre Vilque, Mohamed‐Amine Bekadja, Rene‐Olivier Casasnovas, Remy Gressin, Stéphanie Guidez, Diane Coso, Charles Herbaux, Ibrahim Yakoub‐Agha, Krimo Bouabdallah, Eric Durot & Gandhi Damaj. (2018) Bendamustine‐based conditioning prior to autologous stem cell transplantation (ASCT): Results of a French multicenter study of 474 patients from LYmphoma Study Association (LYSA) centers. American Journal of Hematology 93:6, pages 729-735.
Crossref
Crossref
Sigal Grisariu, Michael Y. Shapira, Reuven Or & Batia Avni. (2018) Thiotepa, Etoposide, Cyclophosphamide, Cytarabine, and Melphalan (TECAM) Conditioning Regimen for Autologous Stem Cell Transplantation in Lymphoma. Clinical Lymphoma Myeloma and Leukemia 18:4, pages 272-279.
Crossref
Crossref
Nmazuo W. Ozuah, Hisham M. Dahmoush, Frederick D. Grant, Leslie E. Lehmann, Ann S. LaCasce, Amy L. Billett & Steven P. Margossian. (2018) Pretransplant functional imaging and outcome in pediatric patients with relapsed/refractory Hodgkin lymphoma undergoing autologous transplantation. Pediatric Blood & Cancer 65:1, pages e26707.
Crossref
Crossref
Mohamed Amine Bekadja, Mohamed Brahimi, Soufi Osmani, Nabil Yafour, Amina Krim, Faiza Serradj, Souad Talhi, Kamila Amani & Rachid Amar Bouhass. (2017) Hematopoietic stem cell transplantation in Algeria. Hematology/Oncology and Stem Cell Therapy 10:4, pages 311-314.
Crossref
Crossref
G Damaj, J Cornillon, K Bouabdallah, R Gressin, S Vigouroux, T Gastinne, F Ranchon, H Ghésquières, G Salles, I Yakoub-Agha & E Gyan. (2017) Carmustine replacement in intensive chemotherapy preceding reinjection of autologous HSCs in Hodgkin and non-Hodgkin lymphoma: a review. Bone Marrow Transplantation 52:7, pages 941-949.
Crossref
Crossref
C Fair, R Shanley, J Rogosheske, A Lazaryan, B McClune, C G Brunstein & V Bachanova. (2017) BEAM conditioning is well-tolerated and yields similar survival in obese and non-obese patients with lymphoma: no requirement for weight-based dose modifications. Bone Marrow Transplantation 52:3, pages 491-493.
Crossref
Crossref
Maurizio Musso, Giuseppe Messina, Nicola Di Renzo, Paolo Di Carlo, Umberto Vitolo, Renato Scalone, Gianpaolo Marcacci, Potito R. Scalzulli, Tiziana Moscato, Rossella Matera, Alessandra Crescimanno, Stella Santarone, Enrico Orciuolo, Anxur Merenda, Vincenzo Pavone, Domenico Pastore, Daniela Donnarumma, Angelo M. Carella, Chiara Ciochetto, Nicola Cascavilla, Anna Mele, Francesco Lanza, Massimo Di Nicola, Erminio Bonizzoni & Antonello Pinto. (2015) Improved outcome of patients with relapsed/refractory Hodgkin lymphoma with a new fotemustine‐based high‐dose chemotherapy regimen. British Journal of Haematology 172:1, pages 111-121.
Crossref
Crossref
Paolo F. Caimi, Basem M. William, Carlos H. Silva Rondon, Pingfu Fu, Brenda W. Cooper, Erica L. Campagnaro, Stanton L. Gerson, Jane Reese-Koc, Robert Fox, Richard J. Creger, Marcos de Lima & Hillard M. Lazarus. (2015) Comparison of 2 Carmustine-Containing Regimens in the Rituximab Era: Excellent Outcomes Even in Poor-Risk Patients. Biology of Blood and Marrow Transplantation 21:11, pages 1926-1931.
Crossref
Crossref
David M. Hockenbery, Simone I. Strasser & George B. McDonald. 2015. Thomas’ Hematopoietic Cell Transplantation. Thomas’ Hematopoietic Cell Transplantation
1140
1160
.
Philip J. Bierman & Auayporn Nademanee. 2015. Thomas’ Hematopoietic Cell Transplantation. Thomas’ Hematopoietic Cell Transplantation
675
695
.
Oscar B. Lahoud, Craig S. Sauter, Paul A. Hamlin & Parastoo Bahrami Dahi. (2015) High-Dose Chemotherapy and Autologous Stem Cell Transplant in Older Patients with Lymphoma. Current Oncology Reports 17:9.
Crossref
Crossref
Yi-Bin Chen, Andrew A. Lane, Brent R. Logan, Xiaochun Zhu, Görgün Akpek, Mahmoud D. Aljurf, Andrew S. Artz, Christopher N. Bredeson, Kenneth R. Cooke, Vincent T. Ho, Hillard M. Lazarus, Richard F. Olsson, Wael Saber, Philip L. McCarthy & Marcelo C. Pasquini. (2015) Impact of Conditioning Regimen on Outcomes for Patients with Lymphoma Undergoing High-Dose Therapy with Autologous Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation 21:6, pages 1046-1053.
Crossref
Crossref
Basem M. William, Mary S. Allen, Fausto R. LoberizaJr.Jr., Robert Gregory Bociek, Philip J. Bierman, James O. Armitage & Julie M. Vose. (2014) Phase I/II Study of Bortezomib-BEAM and Autologous Hematopoietic Stem Cell Transplantation for Relapsed Indolent Non-Hodgkin Lymphoma, Transformed, or Mantle Cell Lymphoma. Biology of Blood and Marrow Transplantation 20:4, pages 536-542.
Crossref
Crossref
M Koenigsmann, J Casper, C Kahl, N Basara, H G Sayer, G Behre, S Theurich, M Christopeit, M Mohren, A Reichle, B Metzner, A Ganser, M Stadler, L Uharek, L Balleisen, A Hinke, R Hinke & D Niederwieser. (2013) Risk-adapted, treosulfan-based therapy with auto- and allo-SCT for relapsed/refractory aggressive NHL: a prospective phase-II trial. Bone Marrow Transplantation 49:3, pages 410-415.
Crossref
Crossref
Maureen M. O’Brien, Michael J. Absalon, Thomas G. Gross & Kara M. Kelly. 2014. Hematopoietic Cell Transplantation in Children with Cancer. Hematopoietic Cell Transplantation in Children with Cancer
251
301
.
Ines Loverdos & Simon C. Ling. 2014. Diseases of the Liver in Children. Diseases of the Liver in Children
403
422
.
Atul Sharma, Smita Kayal, Sobuhi Iqbal, Prabhat Singh Malik & Vinod Raina. (2013) Comparison of BEAM vs. LEAM regimen in autologous transplant for lymphoma at AIIMS. SpringerPlus 2:1.
Crossref
Crossref
Basem M. William, Fausto R. LoberizaJr.Jr., Victoria Whalen, Philip J. Bierman, R. Gregory Bociek, Julie M. Vose & James O. Armitage. (2013) Impact of Conditioning Regimen on Outcome of 2-Year Disease-Free Survivors of Autologous Stem Cell Transplantation for Hodgkin Lymphoma. Clinical Lymphoma Myeloma and Leukemia 13:4, pages 417-423.
Crossref
Crossref
Ji‐Won Kim, Hyun Jung Lee, Hyeon Gyu Yi, Byung‐Su Kim, Soo‐Mee Bang, Jin Seok Kim, Inho Kim, Sung‐Soo Yoon, Jong Seok Lee, Chul Soo Kim, Seonyang Park & Byoung Kook Kim. (2012) Mitoxantrone, etoposide, cytarabine, and melphalan (NEAM) followed by autologous stem cell transplantation for patients with chemosensitive aggressive non‐Hodgkin lymphoma. American Journal of Hematology 87:5, pages 479-483.
Crossref
Crossref
Shivani Srivastava, David Jones, Lisa L. Wood, Jennifer E. Schwartz, Robert P. NelsonJr.Jr., Rafat Abonour, Angie Secrest, Elizabeth Cox, Jay Baute, Cheryl Sullivan, Kathleen Kane, Michael J. Robertson & Sherif S. Farag. (2011) A Phase I Trial of High-Dose Clofarabine, Etoposide, and Cyclophosphamide and Autologous Peripheral Blood Stem Cell Transplantation in Patients with Primary Refractory and Relapsed and Refractory Non-Hodgkin Lymphoma. Biology of Blood and Marrow Transplantation 17:7, pages 987-994.
Crossref
Crossref
Didier Decaudin, Nicolas Mounier, Hervé Tilly, Vincent Ribrag, Hervé Ghesquières, Krimo Bouabdallah, Franck Morschhauser, Bertrand Coiffier, Steven Le Gouill, Serge Bologna, Richard Delarue, Anne Huynh, André Bosly, Josette Brière & Christian Gisselbrecht. (2011) 90Y Ibritumomab Tiuxetan (Zevalin) Combined With BEAM (Z -BEAM) Conditioning Regimen Plus Autologous Stem Cell Transplantation in Relapsed or Refractory Low-grade CD20-positive B-cell Lymphoma. A GELA Phase II Prospective Study. Clinical Lymphoma Myeloma and Leukemia 11:2, pages 212-218.
Crossref
Crossref
Panagiotis Samaras, Marcel Blickenstorfer, Raffaele Daniele Siciliano, Sarah R. Haile, Elefteri M. Buset, Ulf Petrausch, Axel Mischo, Hanspeter Honegger, Urs Schanz, Georg Stussi, Rolf A. Stahel, Alexander Knuth, Frank Stenner-Liewen & Christoph Renner. (2010) Pegfilgrastim reduces the length of hospitalization and the time to engraftment in multiple myeloma patients treated with melphalan 200 and auto-SCT compared with filgrastim. Annals of Hematology 90:1, pages 89-94.
Crossref
Crossref
George B. McDonald. 2011. Vascular Liver Disease. Vascular Liver Disease
149
163
.
M Musso, R Scalone, G Marcacci, F Lanza, N Di Renzo, N Cascavilla, P Di Bartolomeo, A Crescimanno, T Perrone & A Pinto. (2009) Fotemustine plus etoposide, cytarabine and melphalan (FEAM) as a new conditioning regimen for lymphoma patients undergoing auto-SCT: a multicenter feasibility study. Bone Marrow Transplantation 45:7, pages 1147-1153.
Crossref
Crossref
Chuntao Zhang, Juan Shan, Li Feng, Jun Lu, Zheng Xiao, Lei Luo, Chengwen Li, Yingjia Guo & Youping Li. (2010)
The effects of immunosuppressive drugs on CD4
+
CD25
+
regulatory T cells: a systematic review of clinical and basic research
. Journal of Evidence-Based Medicine 3:2, pages 117-129.
Crossref
Crossref
George B. McDonald. (2010) Hepatobiliary Complications of Hematopoietic Cell Transplantation, 40 Years On. Hepatology 51:4, pages 1450-1460.
Crossref
Crossref
Chuntao Zhang, Juan Shan, Jun Lu, Yuchuan Huang, Li Feng, Dan Long, Shengfu Li, Quansheng Li & Youping Li. (2010) Rapamycin in combination with donor-specific CD4+CD25+Treg cells amplified in vitro might be realize the immune tolerance in clinical organ transplantation. Cellular Immunology 264:2, pages 111-113.
Crossref
Crossref
Anne M. Larson & George B. McDonald. 2010. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. Sleisenger and Fordtran's Gastrointestinal and Liver Disease
537
555.e6
.
Philip J. Bierman & Gordon L. Phillips. 2009. Hematopoietic Stem Cell Transplantation. Hematopoietic Stem Cell Transplantation
357
397
.
Luciano J. Costa, Ivana N. Micallef, David J. Inwards, Patrick B. Johnston, Luis F. Porrata, Mark R. Litzow & Stephen M. Ansell. (2008) Effect of the dose per body weight of conditioning chemotherapy on severity of mucositis and risk of relapse after autologous haematopoietic stem cell transplantation in relapsed diffuse large B cell lymphoma. British Journal of Haematology 143:2, pages 268-273.
Crossref
Crossref
Bradford S. Hoppe, Craig H. Moskowitz, Daniel A. Filippa, Chaya S. Moskowitz, Tarun Kewalramani, Andrew D. Zelenetz & Joachim Yahalom. (2008) Involved-Field Radiotherapy Before High-Dose Therapy and Autologous Stem-Cell Rescue in Diffuse Large-Cell Lymphoma: Long-Term Disease Control and Toxicity. Journal of Clinical Oncology 26:11, pages 1858-1864.
Crossref
Crossref
. (2007) Current Awareness in Hematological Oncology. Hematological Oncology 25:2, pages 98-105.
Crossref
Crossref